Illumina Inc
(NAS:ILMN)
$
140.6
-4.55 (-3.13%)
Market Cap: 22.30 Bil
Enterprise Value: 24.76 Bil
PE Ratio: 0
PB Ratio: 10.45
GF Score: 79/100 Illumina Inc at Barclays Global Healthcare Conference Transcript
Mar 13, 2019 / 03:15PM GMT
Release Date Price:
$299.64
(+0.98%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
We're going to do our audience response questions. As we'll kick that off, please use the BlackBerry-type devices. First question, what do you view as Illumina's organic growth profile over the next 3 years?
(Voting)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
I think this might be an easy one here. We do ask the same question for every company. We have some naysayers but 2/3 in the double digits. Next question. How confident is your outlook for growth in China, which has been an important growth for Illumina?
(Voting)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Kind of right down the middle split. And then finally, how would you like to see Sam deploying capital in 2019?
(Voting)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Interesting.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot